Pancreatic cancer is one of the deadliest forms of cancer—because it is so hard to detect, cases are typically caught in the late stages of the disease. A person can live with pancreatic cancer for ...

Patients most likely to benefit from the blood test include those with a higher genetic risk, a family history of pancreatic ...

Learn about a new blood test that could allow physicians to detect pancreatic cancer in its earliest stages by combining ...

The results of an international study suggest that an investigational blood test combining AI and biomarkers may help detect pancreatic cancer earlier, which raises the possibility of identifying ...

The National Cancer Institute estimates that about 67,000 people will be diagnosed with pancreatic cancer in 2026.

An investigational blood test may allow for detection of pancreatic cancer at its earliest stages when it is potentially curable, according to prospective study results.The liquid biopsy also ...

An experimental blood test can spot one of the deadliest forms of cancer at its earliest stages. The Panxeon test has shown ...

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the country, ...

Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...

The new test was developed by scientists at California-based City of Hope, a nonprofit cancer and diabetes research and treatment center.

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the country, ...

Researchers at City of Hope led the development of an investigational blood test that could detect pancreatic cancer at its ...